GOLGA2 and myopathy: Recessive loss of function variants in GOLGA2 was linked to a neurological phenotype defined by microcephaly, seizures, and myopathy [16], in turn indicating the impact of GM130 on proper integrity and function of both the nervous system and skeletal muscle.